Clinical Trial, Phase II

3 trials

Sponsors

Fujimura Taku, Ogawa Keiko, Takeshi Masuda

Conditions

Cutaneous Hemangiosarcomanon-small cell lung cancertrigeminal neuralgia trigeminal neuralgia, idiopathic trigeminal neuralgia, typical trigeminal neuralgia, carbamazepine refractory

Phase 2

Placebo-controlled randomized controlled phase II trial of Goreisan in combination with carbamazepine in patients trigeminal neuralgia

Active, not recruitingJPRN-jRCT2061220090

Ogawa Keikotrigeminal neuralgia trigeminal neuralgia, idiopathic trigeminal neuralgia, typical trigeminal neuralgia, carbamazepine refractory

Start: 2023-01-30Target: 24Updated: 2026-06-29

Phase II study of the safety and efficacy of TM5614 in combination with Paclitaxel for cutaneous angiosarcoma

Active, not recruitingJPRN-jRCT2021230016

Fujimura TakuCutaneous Hemangiosarcoma

Start: 2023-10-25Target: 16Updated: 2026-06-29

A Phase II Investigator-Initiated Clinical Trial Evaluating the Efficacy and Safety of Combination Therapy with a PAI-1 Inhibitor (TM5614) and Immune Checkpoint Inhibitor Consolidation Therapy following Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (TM-Alliance study)

RecruitingJPRN-jRCT2061260001

Takeshi Masudanon-small cell lung cancer

Start: 2026-04-06Target: 27Updated: 2026-06-29